1417825-20-7

Basic information

• Product Name: 1-(3-bromo-[1,2,4]thiadiazol-5-yl)-4-[2-(4-methoxy-phenyl)-ethyl]-piperazine
• Synonyms: 1-(3-bromo-[1,2,4]thiadiazol-5-yl)-4-[2-(4-methoxy-phenyl)-ethyl]-piperazine
• CAS NO: 1417825-20-7
• Molecular Weight: 383.312
• Mol File: 1417825-20-7.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1-(3-bromo-[1,2,4]thiadiazol-5-yl)-4-[2-(4-methoxy-phenyl)-ethyl]-piperazine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3-bromo-[1,2,4]thiadiazol-5-yl)-4-[2-(4-methoxy-phenyl)-ethyl]-piperazine(1417825-20-7)
• EPA Substance Registry System: 1-(3-bromo-[1,2,4]thiadiazol-5-yl)-4-[2-(4-methoxy-phenyl)-ethyl]-piperazine(1417825-20-7)

Safety Data

• Hazardous Substances Data: 1417825-20-7(Hazardous Substances Data)

Upstream product

• 37159-60-7 3-bromo-5-chloro-[1,2,4]thiadiazole 

Downstream Products

• 1423042-07-2 1-[3-(4,4-difluoropiperidin-1-yl)-[1,2,4]thiadiazol-5-yl]-4-[2-(4-methoxyphenyl)ethyl]piperazine 

Relevant articles and documents

1, 2, 4-Thiadiazol-5-Ylpiperazine derivatives useful in the treatment of neurodegenerative diseases

The present invention relates to a compound of formula (IA) The present invention also relates to the use of the compound of formula IA for treating certain neurodegenerative disorders characterized by cytotoxic TAU misfolding and/or aggregation.

1, 2, 4 -THIADIAZOL- 5 -YLPIPERAZINE DERIVATIVES USEFUL IN THE TREATMENT NEURODEGENERATIVE DISEASES

The present invention relates to a compound of formula (IA) The present invention also relates to the use of the compound of formula IA for treating certain neurodegenerative disorders characterized by cytotoxic TAU misfolding and/or aggregation.